|
May 7, 2008 Issue #415 Recommend
Us
 Does adding a little simple resistance to your exercise actually make a difference? Have your patients try this weeks Upper-body resistance training exercises: Double-arm row and lat pull-down shared with us by Dr. Sheri Colberg, Ph.D., FACSM and see the difference yourself.
The pharmaceutical industry is pressing the Food and Drug Administration for greater freedom to give doctors copies of scientific studies about experimental uses of their drugs. And the FDA is considering lighter restrictions. Does this mean we will get label disclaimers like nutritional products? Will manufacturers have put on the label "These statements have not been evaluated by the FDA and this product has never been properly tested to treat cure or ...........? We have the inside scoop on what they are trying to do from the San Francisco Chronicle.
Have you ever heard of an enzyme known as fructose 1,6 bisphosphatase (FBPase) ? Well get ready as it seems this enzyme is a key component of the pathway responsible for the production of glucose known as the gluconeogenesis pathway. Targeting FBPase represents a new therapeutic approach, and it was discovered by Metabasis, who just met a primary efficacy endpoint to reduce fasting plasma glucose in its Phase IIa clinical trial using compound MB07803. Look to learn more about the FBPase enzyme in the future.
dLifeTV, May 11, 7PM ET on CNBC
Practical advice for coping with the emotional ups and downs of diabetes; a Bishop who spreads the message of diabetes awareness to the homeless; and stirring up soup in the dLife kitchen. Plus, Jim Turner remembers his diagnosis day. Tune in for another great episode of dLifeTV on: Sundays on CNBC at 6:00 PM ET, 5:00 PM CT, and 3:00 PM PT
We can make a difference!
*************************
More Current News on Diabetes
*************************
Item #3: Coversyl(r) Protects Hypertensive Patients Against New-Onset Diabetes
Item #6: Regular Exercise In Middle Age Delays Aging By 12 Years
Item #9: Fenofibrate Does Not Halt Atherosclerosis in Patients With Diabetes
Item #10: Impact of Metformin vs. Repaglinide on Cardiovascular Risk With Type 2's
Item #11: 4 Steps to Reverse the Damage from Fast Food Diets
Item #15: Family Physicians Can Successfully Initiate Insulin Therapy
Check out this weeks "Test Your DIABETES Knowledge" question.
LIVE WEBCAST:
Dr. Bernstein will participate in another 60 minute Tele-Seminar on May 27th, at 7:00 PM CST, 8:00 PM EST and 5:00 PM West Coast time, that we invite you to attend, and ask your patients to attend. In addition to calling in, this upcoming call will also be broadcast through a LIVE web-cast on the Internet. Don't miss it. Click here to register for this free teleconference.
http://www.diabetes911.net/askdrb/index.php
Dave Joffe, Editor-in-Chief, CDE, FACA
Top
Diabetes Stories
 Dangerously High Blood Glucose Levels Explained By Genetic Breakthrough*
Prediabetes Can Be Reversed*
Aspirin for The Prevention of Diabetes*
TZD's Triple The Risk for Fracture*
Possible New Therapy to Replenish Betacells Without Stemcells*
Tight Blood Pressure Control Fails to Stall Kidney Disease in Blacks*
Study Ties Obesity, Inflammatory Proteins to Heart Failure Risk*
Model Predicts Pill Combination Could Prevent 4.5 Million Deaths*
Diabetes Education Reduces Hospitalizations
Dave Joffe, Editor-in-Chief,
CDE, FACA
NewsFlash
Prediabetes Can Be Reversed - But we need to find those that have prediabetes and don't know it.
See This Weeks' Item #2
Aspirin for The Prevention of Diabetes - Aspirin can lower blood sugars.
See this Weeks' Item #3 |
